Hospital Outcomes of Community-Acquired SARS-CoV-2 Omicron Variant Infection Compared With Influenza Infection in Switzerland
Lea Portmann(Interface Politikstudien (Switzerland)), Marie-Céline Zanella Terrier, Anne Iten(University Hospital of Geneva), M. Roelens(BIOASTER), Peter W. Schreiber(University Hospital of Zurich), Christoph Berger(University Children's Hospital Zurich), Rami Sommerstein(University of Bern), Nicolas Troillet(Hôpital du Valais), Georg Fröhlich, Ulrich Heininger(University Children’s Hospital Basel), Stephan Harbarth(University Hospital of Geneva), Amaury Thiabaud(University of Geneva), Sarah Tschudin‐Sutter(University of Basel), Andreas F. Widmer(University of Basel), Philipp Jent(University of Bern), Yvonne Nussbaumer, Marlieke E.A. de Kraker(University Medical Center Groningen), Domenica Flury, Michael Büttcher, Danielle Vuichard‐Gysin
Cited by 61
Related Papers
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
|Clinical Microbiology and Infection|2021|1k
Mortality and Hospital Stay Associated with Resistant Staphylococcus aureus and Escherichia coli Bacteremia: Estimating the Burden of Antibiotic Resistance in Europe
|PLoS Medicine|2011|600
Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
|Journal of the American Heart Association|2020|279
Neonatal Sepsis of Early Onset, and Hospital-Acquired and Community-Acquired Late Onset: A Prospective Population-Based Cohort Study
|The Journal of Pediatrics|2018|260
Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed
|Archive ouverte UNIGE (University of Geneva)|2022|221